| Identification | Back Directory | [Name]
30-Hydroxygambogic acid | [CAS]
881027-36-7 | [Synonyms]
30-Hydroxygambogic acid
S-30-Hydroxygambogic acid
30-Hydroxyepigambogic acid
30-Hydroxygambogic acid(C2-S)
(2Z)-2-(Hydroxymethyl)-4-[(1R,3aS,5S,11S,14aS)-3a,4,5,7-tetrahydro-8-hydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-butenoic acid
2-Butenoic acid, 2-(hydroxymethyl)-4-[(1R,3aS,5S,11S,14aS)-3a,4,5,7-tetrahydro-8-hydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,11H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-, (2Z)- | [Molecular Formula]
C38H44O9 | [MOL File]
881027-36-7.mol | [Molecular Weight]
644.75 |
| Hazard Information | Back Directory | [Description]
30-Hydroxygambogic acid exhibits significant cytotoxicities against the human leukemia K562/S and the corresponding doxorubicin-resistant K562/R cell lines. |
|
|